RENAL TRANSPLANTATION

This early-stage study tested a new approach to help kidney transplant recipients stop their daily anti-rejection drugs. Eight adults received donor stem cells along with a special drug combination, with the goal of safely weaning them off all immunosuppression. The main focus wa…

This study looked at whether the usual vitamin D supplement (cholecalciferol) helps children with chronic kidney disease, kidney transplants, or nephrotic syndrome reach healthy vitamin D levels. 43 children took a single high-dose vitamin D vial, and researchers checked their vi…

This study looked at two types of exercise—whole body vibration and aerobic training—in 60 adults who had a kidney transplant. The goal was to see which one better reduced inflammation (measured by interleukin-6) and improved endurance. Participants did their assigned exercise an…

This study tested a new drug combination (siplizumab plus belatacept) against standard care in 76 kidney transplant patients. The goal was to see if the new combo is safer and helps the new kidney work better. Participants were followed for 12 months after transplant.

This study looked at 346 kidney transplant patients to see if a biopsy taken 3 months after surgery could help doctors better manage anti-rejection drugs. Patients with mild signs of rejection were given extra treatment, while those with no inflammation had their steroids reduced…

This study tested whether keeping hemoglobin at different levels improves quality of life and slows kidney damage in people who have had a kidney transplant and now have chronic graft dysfunction. About 128 adults who received a transplant 1 to 20 years ago and have reduced kidne…

This study looked at 40 kidney transplants to see if testing the fluid used to preserve donor kidneys could help predict how well the kidney will work after transplant. Researchers measured substances in the fluid and compared them to early kidney function. The goal is to find be…

This study involved 45 adults who received a kidney transplant. Researchers wanted to learn more about how the drug Advagraf (a type of tacrolimus) works in the body right after transplant and a few months later. The goal was to find better ways to give the right dose of this med…